Carbamoyloximes as novel non-competitive mGlu5 receptor antagonists

被引:21
作者
Galambos, Janos [1 ]
Wagner, Gabor [1 ]
Nogradi, Katalin [1 ]
Bielik, Attila [1 ]
Molnar, Laszlo [1 ]
Bobok, Amrita [1 ]
Horvath, Attila [1 ]
Kiss, Bela [1 ]
Kolok, Sandor [1 ]
Nagy, Jozsef [1 ]
Kurko, Dalma [1 ]
Bakk, Monika L. [1 ]
Vastag, Monika [1 ]
Saghy, Katalin [1 ]
Gyertyan, Istvan [1 ]
Gal, Krisztina [1 ]
Greiner, Istvan [1 ]
Szombathelyi, Zsolt [1 ]
Keseru, Gyoergy M. [1 ]
Domany, Gyoergy [1 ]
机构
[1] Gedeon Richter Plc, H-1475 Budapest, Hungary
关键词
mGluR5 non-competitive antagonist; carbamoyloxime; METABOTROPIC GLUTAMATE RECEPTORS; ALLOSTERIC MODULATORS; BRAIN; PHARMACOLOGY; SUBTYPE-5; DISCOVERY; FENOBAM; POTENT;
D O I
10.1016/j.bmcl.2010.06.075
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Hit-to-lead optimization of a HTS hit led to new carbamoyloxime derivatives. After identification of an advanced hit (8d) the CYP enzyme inhibitory activity of this class of compounds was successfully eliminated. Systematic exploration of different parts of the advanced hit led us to some promising lead compounds with mGluR5 affinities comparable to that of MPEP. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4371 / 4375
页数:5
相关论文
共 34 条
[1]   Coordinate regulation of metabotropic glutamate receptors [J].
Alagarsamy, S ;
Sorensen, SD ;
Conn, PJ .
CURRENT OPINION IN NEUROBIOLOGY, 2001, 11 (03) :357-362
[2]  
ALLGEIER H, 2007, Patent No. 9902497
[3]   Group I metabotropic glutamate receptors: Implications for brain diseases [J].
Bordi, F ;
Ugolini, A .
PROGRESS IN NEUROBIOLOGY, 1999, 59 (01) :55-79
[4]   COMPARATIVE STUDY OF 2 PROCEDURES USED IN DETERMINATION OF HEPATIC MICROSOMAL ANILINE HYDROXYLATION [J].
CHHABRA, RS ;
FOUTS, JR ;
GRAM, TE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1972, 22 (01) :50-&
[5]   Pharmacology and functions of metabotropic glutamate receptors [J].
Conn, PJ ;
Pin, JP .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1997, 37 :205-237
[6]  
Gal K., 2007, Patent No. [WO2007039782A1, 2007039782]
[7]  
Gal K., 2007, [No title captured], Patent No. 2007039781
[8]  
GALAMBOS J, 2007, Patent No. 2007072089
[9]   [3H]-M-MPEP, a potent, subtype-selective radioligand for the metabotropic glutamate receptor subtype 5 [J].
Gasparini, F ;
Andres, H ;
Flor, PJ ;
Heinrich, M ;
Inderbitzin, W ;
Lingenhöhl, K ;
Müller, H ;
Munk, VC ;
Omilusik, K ;
Stierlin, C ;
Stoehr, N ;
Vranesic, I ;
Kuhn, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (03) :407-409
[10]  
Gasparini F, 2008, CURR OPIN DRUG DISC, V11, P655